Drug stocks mixed;
Drug stocks were mixed in early action Thursday with shares of Myriad Genetics Inc. climbing on news that it has signed a deal with Swedish drug conglomerate H. Lundbeck A/S for the European commercialization of Myriad's Alzheimer's drug candidate Flurizan.
US stocks were mixed Tuesday, led higher by energy and pharmaceutical shares but weighed down by the financial and carmaking sectors.